clinical trial · NCT05975424
LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1
Spinal Cord InjuriesMagnetic Resonance Imaging (MRI)
brief summary
This is a LTFU study for cervical SCI subjects that were administered AST-OPC1 cells in the main study AST-OPC1-01.
started
Jun 13, 2018
primary completion
Jan 14, 2033
completion
Jan 14, 2033
last updated
Aug 21, 2024
detailed description
Study AST-OPC1-02 is a Phase 1/2a open-label, multi-center long term follow-up (LTFU) study for twenty-five (25) subjects with cervical SCI that were administered AST-OPC1 cells in the main dose-escalation study AST-OPC1-01. The purpose of this study is to monitor long-term safety in subjects for 15 years post AST-OPC1 administration.
official title
A Long-term Follow-up Study of Subjects With Cervical Spinal Cord Injuries Who Received AST-OPC1 in Protocol AST-OPC1-01
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol